...

ECZACIBAŞI
PHARMACEUTICAL AND
INDUSTRIAL INVESTMENT CO.

FINANCIAL INFORMATION AND SUSTAINABILITY

2025/03

2024/03

Revenue

2.127.017

2.864.260

Gross Profit

730.135

1.169.809

Operating Profit

-49.989

540.100

Depreciation and Amortisation

196.425

266.275

EBITDA

146.436

806.375

Net Income

1.538.297

622.003

2025/03

2024/12

Total Assets

63.562.660

61.856.826

Total Shareholder's Equity

50.942.992

49.404.695

Total Current Assets

10.542.879

8.352.211

Total Current Liabilities

4.425.312

4.136.611

2025/03

2014/12

Liquidity Ratio

1,89

1,49

Current Ratio

2,38

2,02

Total Liabilities / Total Assets

0,20

0,20

Total Shareholders' Equity / Total Assets

0,80

0,80

Total Shareholders' Equity / Total Liabilities

4,04

3,97

2025/03

2024/12

Net Income / Total Shareholders' Equity

0,03

0,02

Net Income / Total Assets

0,02

0,02

Net Income / Revenue

0,72

0,12

Year

Date

Free Issue (%)

Right Issue (%)

Before (TRY)

Now (TRY)

1992

11.11.1992

70

70

150,000

360,000

1994

16.06.1994

115

20

360,000

846,000

1995

13.09.1995

80

-

846,000

1,522,800

1996

25.07.1996

100

-

1,522,800

3,045,600

1999

26.03.1999

300

-

3,045,600

12,182,400

2003

14.05.2003

200

-

12,182,400

36,547,400

2004

13.01.2004

400

-

36,547,200

182,736,000

2008

30.07.2008

200

-

182,736,000

548,208,000

2016

03.11.2016

25

-

137,052,000

685,260,000

Yearly Profit Distribution

2003

28.06.2004

15

13,5

15

-

2004

31.05.2005

7

6,3

7

-

2005

-

-

-

-

-

2006

-

-

-

-

-

2007

26.05.2008

15

12,75

15

-

2008

26.05.2009

11,3

9,605

11,3

2009

25.05.2010

7

5,95

7

2010

24.05.2011

7

5,95

7

2011

19.06.2012

10

8,5

10

-

2012

28.05.2013

10

8,5

10

-

2013

06.05.2014

9,6

8,16

9,6

-

2014

05.05.2015

8

6,8

8

-

2015

10.05.2016

40

34

40

-

2016

08.05.2017

50

42,5

50

-

2017

22.05.2018

20

17

20

-

2018

20.05.2019

30

25,5

30

-

2019

14.04.2020

7,3

6,205

7,3

-

2020

26.04.2021

22

18,7

22

-

2021

24.05.2022

29,2

26,28

29,2

-

2022

25.04.2023

41

36,9

41

-

2023

05.06.2024

118

106.2

118

-

2024

14.05.2025

175,12

148,85

175,12

-

...

ABOUT US

...

CORPORATE MANAGEMENT

...

ANNOUNCEMENTS AND
PRESENTATIONS

...

GENERAL ASSEMBLY